Catalyst Wire Dossier Catalyst Wire Dossier

BAX 326

recombinant factor IX · Baxalta/Shire
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BAX 326, covering 2013-11-25 to 2018-09-10. Get the full timeline:

Most recent: Clinical Trial Update: BAX 326 (rFIX) Continuation Study [Phase 3]

See pricing